A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers.

Janzic, Urska; Bidovec-Stojkovic, Urska; Korosec, Peter; Mohorcic, Katja; Mrak, Loredana; Caks, Marina; Ravnik, Maja; Skof, Erik; Rijavec, Matija

Janzic, Urska; Bidovec-Stojkovic, Urska; Korosec, Peter; Mohorcic, Katja; Mrak, Loredana; Caks, Marina; Ravnik, Maja; Skof, Erik; Rijavec, Matija.

Afiliación

Janzic U; Department of Medical Oncology, University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Bidovec-Stojkovic U; Medical Faculty Ljubljana, University of Ljubljana, 1000 Ljubljana, Slovenia.
Korosec P; Laboratory for Clinical Immunology and Molecular Genetics, University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Mohorcic K; Laboratory for Clinical Immunology and Molecular Genetics, University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Mrak L; Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Caks M; Department of Medical Oncology, University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Ravnik M; Department of Medical Oncology, University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Skof E; Department of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Rijavec M; Department of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.

Vaccines (Basel) ; 11(6)2023 May 23.

Article en En | MEDLINE | ID: mdl-37376406

Palabras clave

COVID-19 vaccination; booster third dose; immunogenicity; solid cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Eslovenia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google